Filtros : "Cancer" Removido: "Souza, Cármino A." Limpar

Filtros



Refine with date range


  • Source: Cancer. Unidade: FM

    Subjects: NEOPLASIAS MAMÁRIAS, QUALIDADE DE VIDA NO TRABALHO, SOBREVIDA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LANDEIRO, Luciana C. G. et al. Return to work after breast cancer diagnosis: an observational prospective study in Brazil. Cancer, v. 124, n. 24, p. 4700-4710, 2018Tradução . . Disponível em: https://doi.org/10.1002/cncr.31735. Acesso em: 03 jul. 2024.
    • APA

      Landeiro, L. C. G., Gagliato, D. M., Fede, A. B., Fraile, N. M., Lopez, R. M., Fonseca, L. G. da, et al. (2018). Return to work after breast cancer diagnosis: an observational prospective study in Brazil. Cancer, 124( 24), 4700-4710. doi:10.1002/cncr.31735
    • NLM

      Landeiro LCG, Gagliato DM, Fede AB, Fraile NM, Lopez RM, Fonseca LG da, Petry V, Testa L, Hoff PMG, Mano MS. Return to work after breast cancer diagnosis: an observational prospective study in Brazil [Internet]. Cancer. 2018 ; 124( 24): 4700-4710.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.31735
    • Vancouver

      Landeiro LCG, Gagliato DM, Fede AB, Fraile NM, Lopez RM, Fonseca LG da, Petry V, Testa L, Hoff PMG, Mano MS. Return to work after breast cancer diagnosis: an observational prospective study in Brazil [Internet]. Cancer. 2018 ; 124( 24): 4700-4710.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.31735
  • Source: Cancer. Unidade: IQ

    Subjects: INTERLEUCINAS, NEOPLASIAS DOS GENITAIS MASCULINOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PASQUALINI, Renata et al. Targeting the interleukin-11 receptor a in metastatic prostate cancer: a first-in-man study. Cancer, v. 121, n. 14, p. 2411-2421, 2015Tradução . . Disponível em: https://doi.org/10.1002/cncr.29344. Acesso em: 03 jul. 2024.
    • APA

      Pasqualini, R., Millikan, R. E., Christianson, D. R., Cardó-Vila, M., Driessen, W. H. P., Giordano, R. J., et al. (2015). Targeting the interleukin-11 receptor a in metastatic prostate cancer: a first-in-man study. Cancer, 121( 14), 2411-2421. doi:10.1002/cncr.29344
    • NLM

      Pasqualini R, Millikan RE, Christianson DR, Cardó-Vila M, Driessen WHP, Giordano RJ, Hajitou A, Hoang AG, Wen S, Barnhart KF, Baze WB, Marcott VD, Hawke DH, Do K-A, Navone NM, Efstathiou E, Troncoso P, Lobb RR, Logothetis CJ, Arap W. Targeting the interleukin-11 receptor a in metastatic prostate cancer: a first-in-man study [Internet]. Cancer. 2015 ; 121( 14): 2411-2421.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.29344
    • Vancouver

      Pasqualini R, Millikan RE, Christianson DR, Cardó-Vila M, Driessen WHP, Giordano RJ, Hajitou A, Hoang AG, Wen S, Barnhart KF, Baze WB, Marcott VD, Hawke DH, Do K-A, Navone NM, Efstathiou E, Troncoso P, Lobb RR, Logothetis CJ, Arap W. Targeting the interleukin-11 receptor a in metastatic prostate cancer: a first-in-man study [Internet]. Cancer. 2015 ; 121( 14): 2411-2421.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.29344
  • Source: Cancer. Unidade: FO

    Subjects: METÁSTASE NEOPLÁSICA, CARCINOMA DE CÉLULAS ESCAMOSAS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Sabrina Daniela da et al. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer, v. 120, n. 3, p. 352-362, 2014Tradução . . Disponível em: https://doi.org/10.1002/cncr.28404. Acesso em: 03 jul. 2024.
    • APA

      Silva, S. D. da, Alaoui-Jamali , M. A., Soares, F. A., Carraro, D. M., Brentani, H. P., Hier, M., et al. (2014). TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer, 120( 3), 352-362. doi:10.1002/cncr.28404
    • NLM

      Silva SD da, Alaoui-Jamali MA, Soares FA, Carraro DM, Brentani HP, Hier M, Rogatto SR, Kowalski LP. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target [Internet]. Cancer. 2014 ; 120( 3): 352-362.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.28404
    • Vancouver

      Silva SD da, Alaoui-Jamali MA, Soares FA, Carraro DM, Brentani HP, Hier M, Rogatto SR, Kowalski LP. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target [Internet]. Cancer. 2014 ; 120( 3): 352-362.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.28404
  • Source: Cancer. Unidade: FM

    Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, PROGNÓSTICO, ESTADIAMENTO DE NEOPLASIAS, CARCINOMA DE CÉLULAS ESCAMOSAS, LINFONODOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      EBRAHIMI, Ardalan et al. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality. Cancer, v. 120, n. 13, p. 1968-1974, 2014Tradução . . Disponível em: https://doi.org/10.1002/cncr.28686. Acesso em: 03 jul. 2024.
    • APA

      Ebrahimi, A., Gil, Z., Amit, M., Yen, T. -C., Liao, C. -T., Chaturvedi, P., et al. (2014). The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality. Cancer, 120( 13), 1968-1974. doi:10.1002/cncr.28686
    • NLM

      Ebrahimi A, Gil Z, Amit M, Yen T-C, Liao C-T, Chaturvedi P, Agarwal JP, Kowalski LP, Kohler HF, Kreppel M, Cernea CR, Brandao J, Bachar G, Villaret AB, Fliss D, Fridman E, Robbins KT, Shah JP, Patel SG, Clark JR. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality [Internet]. Cancer. 2014 ; 120( 13): 1968-1974.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.28686
    • Vancouver

      Ebrahimi A, Gil Z, Amit M, Yen T-C, Liao C-T, Chaturvedi P, Agarwal JP, Kowalski LP, Kohler HF, Kreppel M, Cernea CR, Brandao J, Bachar G, Villaret AB, Fliss D, Fridman E, Robbins KT, Shah JP, Patel SG, Clark JR. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality [Internet]. Cancer. 2014 ; 120( 13): 1968-1974.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.28686
  • Source: Cancer. Unidade: ICMC

    Subjects: INFERÊNCIA BAYESIANA, ESTATÍSTICA APLICADA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KIM, Miranda B. et al. Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial. Cancer, v. 119, n. 18, p. 3280\20133286, 2013Tradução . . Disponível em: https://doi.org/10.1002/cncr.28202. Acesso em: 03 jul. 2024.
    • APA

      Kim, M. B., Chen, M. -H., Castro, M. de, Loffredo, M., Kantoff, P. W., & D'Amico, A. V. (2013). Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial. Cancer, 119( 18), 3280\20133286. doi:10.1002/cncr.28202
    • NLM

      Kim MB, Chen M-H, Castro M de, Loffredo M, Kantoff PW, D'Amico AV. Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial [Internet]. Cancer. 2013 ; 119( 18): 3280\20133286.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.28202
    • Vancouver

      Kim MB, Chen M-H, Castro M de, Loffredo M, Kantoff PW, D'Amico AV. Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial [Internet]. Cancer. 2013 ; 119( 18): 3280\20133286.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.28202
  • Source: Cancer. Unidade: FM

    Subjects: TOMOGRAFIA COMPUTADORIZADA POR EMISSÃO DE PÓSITRON, DIAGNÓSTICO CLÍNICO (AVALIAÇÃO), NEOPLASIAS RETAIS (EFEITOS DE DROGAS;EFEITOS DE RADIAÇÃO), EVOLUÇÃO CLÍNICA, QUIMIOTERAPIA ADJUVANTE, RADIAÇÃO IONIZANTE

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PEREZ, Rodrigo Oliva et al. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: Long-term results of a prospective trial (National Clinical Trial 00254683). Cancer, v. 118, n. 14, p. 3501-3511, 2012Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/cncr.26644/pdf. Acesso em: 03 jul. 2024.
    • APA

      Perez, R. O., Habr-Gama, A., Gama-Rodrigues, J., Proscurshim, I., Sao Juliao, G. P., Lynn, P., et al. (2012). Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: Long-term results of a prospective trial (National Clinical Trial 00254683). Cancer, 118( 14), 3501-3511. doi:10.1002/cncr.26644
    • NLM

      Perez RO, Habr-Gama A, Gama-Rodrigues J, Proscurshim I, Sao Juliao GP, Lynn P, Ono CR, Campos FG, Sousa J, Imperiale AR, Nahas SC, Buchpiguel CA. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: Long-term results of a prospective trial (National Clinical Trial 00254683) [Internet]. Cancer. 2012 ; 118( 14): 3501-3511.[citado 2024 jul. 03 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/cncr.26644/pdf
    • Vancouver

      Perez RO, Habr-Gama A, Gama-Rodrigues J, Proscurshim I, Sao Juliao GP, Lynn P, Ono CR, Campos FG, Sousa J, Imperiale AR, Nahas SC, Buchpiguel CA. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: Long-term results of a prospective trial (National Clinical Trial 00254683) [Internet]. Cancer. 2012 ; 118( 14): 3501-3511.[citado 2024 jul. 03 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/cncr.26644/pdf
  • Source: Cancer. Unidade: IFSC

    Subjects: ESPECTROSCOPIA ÓPTICA (APLICAÇÕES), FLUORESCÊNCIA, NEOPLASIAS BUCAIS, PATOLOGIA BUCAL (DIAGNÓSTICO)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SCHWARZ, Richard A. et al. Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy. Cancer, v. 115, n. 8, p. 1669-1679, 2009Tradução . . Disponível em: https://doi.org/10.1002/cncr.24177. Acesso em: 03 jul. 2024.
    • APA

      Schwarz, R. A., Gao, W., Weber, C. R., Kurachi, C., Lee, J. J., El-Naggar, A. K., et al. (2009). Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy. Cancer, 115( 8), 1669-1679. doi:10.1002/cncr.24177
    • NLM

      Schwarz RA, Gao W, Weber CR, Kurachi C, Lee JJ, El-Naggar AK, Kortum RR, Gillenwater AM. Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy [Internet]. Cancer. 2009 ; 115( 8): 1669-1679.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.24177
    • Vancouver

      Schwarz RA, Gao W, Weber CR, Kurachi C, Lee JJ, El-Naggar AK, Kortum RR, Gillenwater AM. Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy [Internet]. Cancer. 2009 ; 115( 8): 1669-1679.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.24177
  • Source: Cancer. Unidade: FMRP

    Subjects: NEOPLASIAS CRANIANAS, NEOPLASIAS ÓSSEAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALMEFTY, Kaith et al. Chordoma and chodrosarcoma: similar, but quite different, skull base tumors. Cancer, v. 110, n. 11, p. 2457-2467, 2007Tradução . . Disponível em: https://doi.org/10.1002/cncr.23073. Acesso em: 03 jul. 2024.
    • APA

      Almefty, K., Pravdenkova, S., Colli, B. O., Al-Mefty, O., & Gokden, M. (2007). Chordoma and chodrosarcoma: similar, but quite different, skull base tumors. Cancer, 110( 11), 2457-2467. doi:10.1002/cncr.23073
    • NLM

      Almefty K, Pravdenkova S, Colli BO, Al-Mefty O, Gokden M. Chordoma and chodrosarcoma: similar, but quite different, skull base tumors [Internet]. Cancer. 2007 ; 110( 11): 2457-2467.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.23073
    • Vancouver

      Almefty K, Pravdenkova S, Colli BO, Al-Mefty O, Gokden M. Chordoma and chodrosarcoma: similar, but quite different, skull base tumors [Internet]. Cancer. 2007 ; 110( 11): 2457-2467.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.23073
  • Source: Cancer. Unidade: IME

    Subjects: CARCINOMA, ANÁLISE DISCRIMINANTE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      STOLF, Beatriz Simonsen et al. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression. Cancer, v. 106, n. 9, p. 1891-1900, 2006Tradução . . Disponível em: https://doi.org/10.1002/cncr.21826. Acesso em: 03 jul. 2024.
    • APA

      Stolf, B. S., Santos, M. M. dos, Simão, D. F., Diaz, J. P., Cristo, E. B., Hirata Júnior, R., et al. (2006). Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression. Cancer, 106( 9), 1891-1900. doi:10.1002/cncr.21826
    • NLM

      Stolf BS, Santos MM dos, Simão DF, Diaz JP, Cristo EB, Hirata Júnior R, Curado MP, Neves EJ, Kowalski LP, Carvalho AF de. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression [Internet]. Cancer. 2006 ; 106( 9): 1891-1900.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.21826
    • Vancouver

      Stolf BS, Santos MM dos, Simão DF, Diaz JP, Cristo EB, Hirata Júnior R, Curado MP, Neves EJ, Kowalski LP, Carvalho AF de. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression [Internet]. Cancer. 2006 ; 106( 9): 1891-1900.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/cncr.21826
  • Source: Cancer. Unidade: FM

    Assunto: PATOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WAJCHENBERG, Bernardo Leo et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer, v. 88, n. 4, p. 711-36, 2000Tradução . . Acesso em: 03 jul. 2024.
    • APA

      Wajchenberg, B. L., Pereira, M. A. A., Mendonça, B. B. de, Latronico, A. C., Carneiro, P. C., Alves, V. A. F., et al. (2000). Adrenocortical carcinoma: clinical and laboratory observations. Cancer, 88( 4), 711-36.
    • NLM

      Wajchenberg BL, Pereira MAA, Mendonça BB de, Latronico AC, Carneiro PC, Alves VAF, Zerbini MCN, Liberman B, Gomes GC, Kirschner MA. Adrenocortical carcinoma: clinical and laboratory observations. Cancer. 2000 ; 88( 4): 711-36.[citado 2024 jul. 03 ]
    • Vancouver

      Wajchenberg BL, Pereira MAA, Mendonça BB de, Latronico AC, Carneiro PC, Alves VAF, Zerbini MCN, Liberman B, Gomes GC, Kirschner MA. Adrenocortical carcinoma: clinical and laboratory observations. Cancer. 2000 ; 88( 4): 711-36.[citado 2024 jul. 03 ]
  • Source: Cancer. Unidades: EEFE, FM

    Assunto: ONCOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MILANEZ, J R C et al. Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer. Cancer, v. 75, n. ju 1995, p. 2688-91, 1995Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19950601)75:11%3C2688::aid-cncr2820751108%3E3.0.co;2-3. Acesso em: 03 jul. 2024.
    • APA

      Milanez, J. R. C., Vargas, F. S., Filomeno, L. T. B., Teixeira, L., Fernandez, A., Jatene, F. B., & Light, R. W. (1995). Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer. Cancer, 75( ju 1995), 2688-91. doi:10.1002/1097-0142(19950601)75:11%3C2688::aid-cncr2820751108%3E3.0.co;2-3
    • NLM

      Milanez JRC, Vargas FS, Filomeno LTB, Teixeira L, Fernandez A, Jatene FB, Light RW. Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer [Internet]. Cancer. 1995 ;75( ju 1995): 2688-91.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19950601)75:11%3C2688::aid-cncr2820751108%3E3.0.co;2-3
    • Vancouver

      Milanez JRC, Vargas FS, Filomeno LTB, Teixeira L, Fernandez A, Jatene FB, Light RW. Intrapleural talc for the treatment of malignant pleural effusions secondary to breast cancer [Internet]. Cancer. 1995 ;75( ju 1995): 2688-91.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19950601)75:11%3C2688::aid-cncr2820751108%3E3.0.co;2-3
  • Source: Cancer. Unidade: FM

    Assunto: ONCOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BREM, S et al. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer, v. 70, n. 11, p. 2673-80, 1992Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19921201)70:11%3C2673::aid-cncr2820701118%3E3.0.co;2-f. Acesso em: 03 jul. 2024.
    • APA

      Brem, S., Tsanaclis, A. M. C., Gately, S., Gross, J. L., & Herblin, W. F. (1992). Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer, 70( 11), 2673-80. doi:10.1002/1097-0142(19921201)70:11%3C2673::aid-cncr2820701118%3E3.0.co;2-f
    • NLM

      Brem S, Tsanaclis AMC, Gately S, Gross JL, Herblin WF. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors [Internet]. Cancer. 1992 ;70( 11): 2673-80.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19921201)70:11%3C2673::aid-cncr2820701118%3E3.0.co;2-f
    • Vancouver

      Brem S, Tsanaclis AMC, Gately S, Gross JL, Herblin WF. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors [Internet]. Cancer. 1992 ;70( 11): 2673-80.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19921201)70:11%3C2673::aid-cncr2820701118%3E3.0.co;2-f
  • Source: Cancer. Unidade: FM

    Assunto: PATOLOGIA CLÍNICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TSANACLIS, Ana Maria Crous et al. Statin immunolocalization in human brain tumors: detection of noncycling cells using a novel marker of cell quiescence. Cancer, v. 68, n. 4 , p. 786-92, 1991Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19910815)68:4%3C786::aid-cncr2820680421%3E3.0.co;2-p. Acesso em: 03 jul. 2024.
    • APA

      Tsanaclis, A. M. C., Brem, S. S., Stevem, S., Gately, S., Schipper, H. M., & Wang, E. (1991). Statin immunolocalization in human brain tumors: detection of noncycling cells using a novel marker of cell quiescence. Cancer, 68( 4 ), 786-92. doi:10.1002/1097-0142(19910815)68:4%3C786::aid-cncr2820680421%3E3.0.co;2-p
    • NLM

      Tsanaclis AMC, Brem SS, Stevem S, Gately S, Schipper HM, Wang E. Statin immunolocalization in human brain tumors: detection of noncycling cells using a novel marker of cell quiescence [Internet]. Cancer. 1991 ;68( 4 ): 786-92.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19910815)68:4%3C786::aid-cncr2820680421%3E3.0.co;2-p
    • Vancouver

      Tsanaclis AMC, Brem SS, Stevem S, Gately S, Schipper HM, Wang E. Statin immunolocalization in human brain tumors: detection of noncycling cells using a novel marker of cell quiescence [Internet]. Cancer. 1991 ;68( 4 ): 786-92.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19910815)68:4%3C786::aid-cncr2820680421%3E3.0.co;2-p
  • Source: Cancer. Unidade: FM

    Subjects: CARCINOMA, GLÂNDULA TIREOIDE (FISIOPATOLOGIA), AUTÓPSIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BISI, Hélio et al. Prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer, v. no 1989, n. 9, p. 1888-1893, 1989Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19891101)64:9%3C1888::aid-cncr2820640922%3E3.0.co;2-c. Acesso em: 03 jul. 2024.
    • APA

      Bisi, H., Fernandes, V. S. O., Camargo, R. Y. A., Koch, L., Abdo, A. H., & Brito, T. (1989). Prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer, no 1989( 9), 1888-1893. doi:10.1002/1097-0142(19891101)64:9%3C1888::aid-cncr2820640922%3E3.0.co;2-c
    • NLM

      Bisi H, Fernandes VSO, Camargo RYA, Koch L, Abdo AH, Brito T. Prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma [Internet]. Cancer. 1989 ; no 1989( 9): 1888-1893.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19891101)64:9%3C1888::aid-cncr2820640922%3E3.0.co;2-c
    • Vancouver

      Bisi H, Fernandes VSO, Camargo RYA, Koch L, Abdo AH, Brito T. Prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma [Internet]. Cancer. 1989 ; no 1989( 9): 1888-1893.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19891101)64:9%3C1888::aid-cncr2820640922%3E3.0.co;2-c
  • Source: Cancer. Unidade: FM

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      POSSIK, R A et al. Sensitivity, specificity and predictive value of laparoscopy for staging of gastric cancer and for the detection of liver metastases. Cancer, v. 58, p. 1-6, 1987Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19860701)58:1%3C1::aid-cncr2820580102%3E3.0.co;2-k. Acesso em: 03 jul. 2024.
    • APA

      Possik, R. A., Franco, E. L., Pires, D. R., Wohnrath, D. R., & Ferreira, E. A. B. (1987). Sensitivity, specificity and predictive value of laparoscopy for staging of gastric cancer and for the detection of liver metastases. Cancer, 58, 1-6. doi:10.1002/1097-0142(19860701)58:1%3C1::aid-cncr2820580102%3E3.0.co;2-k
    • NLM

      Possik RA, Franco EL, Pires DR, Wohnrath DR, Ferreira EAB. Sensitivity, specificity and predictive value of laparoscopy for staging of gastric cancer and for the detection of liver metastases [Internet]. Cancer. 1987 ;58 1-6.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19860701)58:1%3C1::aid-cncr2820580102%3E3.0.co;2-k
    • Vancouver

      Possik RA, Franco EL, Pires DR, Wohnrath DR, Ferreira EAB. Sensitivity, specificity and predictive value of laparoscopy for staging of gastric cancer and for the detection of liver metastases [Internet]. Cancer. 1987 ;58 1-6.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19860701)58:1%3C1::aid-cncr2820580102%3E3.0.co;2-k
  • Source: Cancer. Unidade: FM

    Assunto: ONCOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALBERTI JUNIOR, O et al. Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes. Cancer, v. 57, n. 5 , p. 1042-5, 1986Tradução . . Disponível em: https://doi.org/10.1002/1097-0142(19860301)57:5%3C1042::aid-cncr2820570528%3E3.0.co;2-f. Acesso em: 03 jul. 2024.
    • APA

      Alberti Junior, O., Brentani, M. M., Goes, J. C. S., Lemos, L. B., & Torloni, H. (1986). Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes. Cancer, 57( 5 ), 1042-5. doi:10.1002/1097-0142(19860301)57:5%3C1042::aid-cncr2820570528%3E3.0.co;2-f
    • NLM

      Alberti Junior O, Brentani MM, Goes JCS, Lemos LB, Torloni H. Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes [Internet]. Cancer. 1986 ;57( 5 ): 1042-5.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19860301)57:5%3C1042::aid-cncr2820570528%3E3.0.co;2-f
    • Vancouver

      Alberti Junior O, Brentani MM, Goes JCS, Lemos LB, Torloni H. Carcinoembryonic antigen. A possible predictor of recurrence in cystosarcoma phyllodes [Internet]. Cancer. 1986 ;57( 5 ): 1042-5.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1002/1097-0142(19860301)57:5%3C1042::aid-cncr2820570528%3E3.0.co;2-f

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024